SLE - Systemic Lupus Erythematosus research hub

MB-CART19.1 in Refractory SLE

This study is testing a new treatment called MB-CART19.1 for severe lupus (SLE) that hasn't responded to other medicines. Researchers want to see if it's safe and effective in people aged 18 and over.